The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Hospital Acquired Infection Control-Global Market Insights and Sales Trends 2024

Hospital Acquired Infection Control-Global Market Insights and Sales Trends 2024

Publishing Date : Dec, 2023

License Type :
 

Report Code : 1807987

No of Pages : 105

Ask Your Query

Synopsis

The global Hospital Acquired Infection Control market size is expected to reach US$ 6985.5 million by 2029, growing at a CAGR of 2.9% from 2023 to 2029. The market is mainly driven by the significant applications of Hospital Acquired Infection Control in various end use industries. The expanding demands from the Hospitals and ICUs, Outpatient Care Centers and Long-term Care Facilities (LTCFs),, are propelling Hospital Acquired Infection Control market. Catheter-associated Urinary Tract Infections (CAUTIs), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Surgical Site Infections (SSIs) segment is estimated at % CAGR for the next seven-year period.

Asia Pacific shows high growth potential for Hospital Acquired Infection Control market, driven by demand from China, the second largest economy with some signs of stabilising, the Hospital Acquired Infection Control market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.

Report Objectives

This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Hospital Acquired Infection Control, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Hospital Acquired Infection Control market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Hospital Acquired Infection Control market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Hospital Acquired Infection Control sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Hospital Acquired Infection Control covered in this report include Pfizer, Roche, Merck, Johnson & Johnson, Abott, Bayer, BD, Kimberly-Clark and Nordion, etc.

The global Hospital Acquired Infection Control market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

  • Pfizer
  • Roche
  • Merck
  • Johnson & Johnson
  • Abott
  • Bayer
  • BD
  • Kimberly-Clark
  • Nordion
  • Cepheid

Global Hospital Acquired Infection Control market, by region:

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, UK, Italy, etc.)
  • Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
  • South America (Brazil, etc.)
  • Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

Global Hospital Acquired Infection Control market, Segment by Type:

  • Catheter-associated Urinary Tract Infections (CAUTIs)
  • Surgical Site Infections (SSIs)
  • Central Line-associated Bloodstream Infections (CLABSIs)
  • Respiratory Infections

Global Hospital Acquired Infection Control market, by Application

  • Hospitals and ICUs
  • Outpatient Care Centers
  • Long-term Care Facilities (LTCFs)

Core Chapters

Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Hospital Acquired Infection Control manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Hospital Acquired Infection Control in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.

Index

1 Hospital Acquired Infection Control Market Overview
1.1 Hospital Acquired Infection Control Product Overview
1.2 Hospital Acquired Infection Control Market Segment by Type
1.2.1 Catheter-associated Urinary Tract Infections (CAUTIs)
1.2.2 Surgical Site Infections (SSIs)
1.2.3 Central Line-associated Bloodstream Infections (CLABSIs)
1.2.4 Respiratory Infections
1.3 Global Hospital Acquired Infection Control Market Size by Type
1.3.1 Global Hospital Acquired Infection Control Market Size Overview by Type (2018-2029)
1.3.2 Global Hospital Acquired Infection Control Historic Market Size Review by Type (2018-2023)
1.3.3 Global Hospital Acquired Infection Control Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Hospital Acquired Infection Control Sales Breakdown by Type (2018-2023)
1.4.2 Europe Hospital Acquired Infection Control Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Hospital Acquired Infection Control Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Hospital Acquired Infection Control Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Hospital Acquired Infection Control Sales Breakdown by Type (2018-2023)
2 Global Hospital Acquired Infection Control Market Competition by Company
2.1 Global Top Players by Hospital Acquired Infection Control Sales (2018-2023)
2.2 Global Top Players by Hospital Acquired Infection Control Revenue (2018-2023)
2.3 Global Top Players by Hospital Acquired Infection Control Price (2018-2023)
2.4 Global Top Manufacturers Hospital Acquired Infection Control Manufacturing Base Distribution, Sales Area, Product Type
2.5 Hospital Acquired Infection Control Market Competitive Situation and Trends
2.5.1 Hospital Acquired Infection Control Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Hospital Acquired Infection Control Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Hospital Acquired Infection Control as of 2022)
2.7 Date of Key Manufacturers Enter into Hospital Acquired Infection Control Market
2.8 Key Manufacturers Hospital Acquired Infection Control Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Hospital Acquired Infection Control Status and Outlook by Region
3.1 Global Hospital Acquired Infection Control Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Hospital Acquired Infection Control Historic Market Size by Region
3.2.1 Global Hospital Acquired Infection Control Sales in Volume by Region (2018-2023)
3.2.2 Global Hospital Acquired Infection Control Sales in Value by Region (2018-2023)
3.2.3 Global Hospital Acquired Infection Control Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Hospital Acquired Infection Control Forecasted Market Size by Region
3.3.1 Global Hospital Acquired Infection Control Sales in Volume by Region (2024-2029)
3.3.2 Global Hospital Acquired Infection Control Sales in Value by Region (2024-2029)
3.3.3 Global Hospital Acquired Infection Control Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Hospital Acquired Infection Control by Application
4.1 Hospital Acquired Infection Control Market Segment by Application
4.1.1 Hospitals and ICUs
4.1.2 Outpatient Care Centers
4.1.3 Long-term Care Facilities (LTCFs)
4.2 Global Hospital Acquired Infection Control Market Size by Application
4.2.1 Global Hospital Acquired Infection Control Market Size Overview by Application (2018-2029)
4.2.2 Global Hospital Acquired Infection Control Historic Market Size Review by Application (2018-2023)
4.2.3 Global Hospital Acquired Infection Control Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Hospital Acquired Infection Control Sales Breakdown by Application (2018-2023)
4.3.2 Europe Hospital Acquired Infection Control Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Hospital Acquired Infection Control Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Hospital Acquired Infection Control Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Hospital Acquired Infection Control Sales Breakdown by Application (2018-2023)
5 North America Hospital Acquired Infection Control by Country
5.1 North America Hospital Acquired Infection Control Historic Market Size by Country
5.1.1 North America Hospital Acquired Infection Control Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Hospital Acquired Infection Control Sales in Volume by Country (2018-2023)
5.1.3 North America Hospital Acquired Infection Control Sales in Value by Country (2018-2023)
5.2 North America Hospital Acquired Infection Control Forecasted Market Size by Country
5.2.1 North America Hospital Acquired Infection Control Sales in Volume by Country (2024-2029)
5.2.2 North America Hospital Acquired Infection Control Sales in Value by Country (2024-2029)
6 Europe Hospital Acquired Infection Control by Country
6.1 Europe Hospital Acquired Infection Control Historic Market Size by Country
6.1.1 Europe Hospital Acquired Infection Control Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Hospital Acquired Infection Control Sales in Volume by Country (2018-2023)
6.1.3 Europe Hospital Acquired Infection Control Sales in Value by Country (2018-2023)
6.2 Europe Hospital Acquired Infection Control Forecasted Market Size by Country
6.2.1 Europe Hospital Acquired Infection Control Sales in Volume by Country (2024-2029)
6.2.2 Europe Hospital Acquired Infection Control Sales in Value by Country (2024-2029)
7 Asia-Pacific Hospital Acquired Infection Control by Region
7.1 Asia-Pacific Hospital Acquired Infection Control Historic Market Size by Region
7.1.1 Asia-Pacific Hospital Acquired Infection Control Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Hospital Acquired Infection Control Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Hospital Acquired Infection Control Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Hospital Acquired Infection Control Forecasted Market Size by Region
7.2.1 Asia-Pacific Hospital Acquired Infection Control Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Hospital Acquired Infection Control Sales in Value by Region (2024-2029)
8 Latin America Hospital Acquired Infection Control by Country
8.1 Latin America Hospital Acquired Infection Control Historic Market Size by Country
8.1.1 Latin America Hospital Acquired Infection Control Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Hospital Acquired Infection Control Sales in Volume by Country (2018-2023)
8.1.3 Latin America Hospital Acquired Infection Control Sales in Value by Country (2018-2023)
8.2 Latin America Hospital Acquired Infection Control Forecasted Market Size by Country
8.2.1 Latin America Hospital Acquired Infection Control Sales in Volume by Country (2024-2029)
8.2.2 Latin America Hospital Acquired Infection Control Sales in Value by Country (2024-2029)
9 Middle East and Africa Hospital Acquired Infection Control by Country
9.1 Middle East and Africa Hospital Acquired Infection Control Historic Market Size by Country
9.1.1 Middle East and Africa Hospital Acquired Infection Control Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Hospital Acquired Infection Control Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Hospital Acquired Infection Control Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Hospital Acquired Infection Control Forecasted Market Size by Country
9.2.1 Middle East and Africa Hospital Acquired Infection Control Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Hospital Acquired Infection Control Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Pfizer
10.1.1 Pfizer Company Information
10.1.2 Pfizer Introduction and Business Overview
10.1.3 Pfizer Hospital Acquired Infection Control Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Pfizer Hospital Acquired Infection Control Products Offered
10.1.5 Pfizer Recent Development
10.2 Roche
10.2.1 Roche Company Information
10.2.2 Roche Introduction and Business Overview
10.2.3 Roche Hospital Acquired Infection Control Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Roche Hospital Acquired Infection Control Products Offered
10.2.5 Roche Recent Development
10.3 Merck
10.3.1 Merck Company Information
10.3.2 Merck Introduction and Business Overview
10.3.3 Merck Hospital Acquired Infection Control Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Merck Hospital Acquired Infection Control Products Offered
10.3.5 Merck Recent Development
10.4 Johnson & Johnson
10.4.1 Johnson & Johnson Company Information
10.4.2 Johnson & Johnson Introduction and Business Overview
10.4.3 Johnson & Johnson Hospital Acquired Infection Control Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Johnson & Johnson Hospital Acquired Infection Control Products Offered
10.4.5 Johnson & Johnson Recent Development
10.5 Abott
10.5.1 Abott Company Information
10.5.2 Abott Introduction and Business Overview
10.5.3 Abott Hospital Acquired Infection Control Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Abott Hospital Acquired Infection Control Products Offered
10.5.5 Abott Recent Development
10.6 Bayer
10.6.1 Bayer Company Information
10.6.2 Bayer Introduction and Business Overview
10.6.3 Bayer Hospital Acquired Infection Control Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Bayer Hospital Acquired Infection Control Products Offered
10.6.5 Bayer Recent Development
10.7 BD
10.7.1 BD Company Information
10.7.2 BD Introduction and Business Overview
10.7.3 BD Hospital Acquired Infection Control Sales, Revenue and Gross Margin (2018-2023)
10.7.4 BD Hospital Acquired Infection Control Products Offered
10.7.5 BD Recent Development
10.8 Kimberly-Clark
10.8.1 Kimberly-Clark Company Information
10.8.2 Kimberly-Clark Introduction and Business Overview
10.8.3 Kimberly-Clark Hospital Acquired Infection Control Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Kimberly-Clark Hospital Acquired Infection Control Products Offered
10.8.5 Kimberly-Clark Recent Development
10.9 Nordion
10.9.1 Nordion Company Information
10.9.2 Nordion Introduction and Business Overview
10.9.3 Nordion Hospital Acquired Infection Control Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Nordion Hospital Acquired Infection Control Products Offered
10.9.5 Nordion Recent Development
10.10 Cepheid
10.10.1 Cepheid Company Information
10.10.2 Cepheid Introduction and Business Overview
10.10.3 Cepheid Hospital Acquired Infection Control Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Cepheid Hospital Acquired Infection Control Products Offered
10.10.5 Cepheid Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Hospital Acquired Infection Control Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Hospital Acquired Infection Control Industrial Chain Analysis
11.4 Hospital Acquired Infection Control Market Dynamics
11.4.1 Hospital Acquired Infection Control Industry Trends
11.4.2 Hospital Acquired Infection Control Market Drivers
11.4.3 Hospital Acquired Infection Control Market Challenges
11.4.4 Hospital Acquired Infection Control Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Hospital Acquired Infection Control Distributors
12.3 Hospital Acquired Infection Control Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock